INS and type 2 diabetes mellitus: A study in human subjects also demonstrated a blunted insulin-mediated decrease in plasma FFA levels after insulin clamp in patients with type 2 diabetes compared to healthy, normoglycemic, or obese individuals (11), thus supporting the clinical significance of the observed effects in this study.